Abstract View

Author(s): Dr. R. Sundhararajan1, Mr. V. V. Venkatachalam*2, S. Ummu Fathima3, A. G. Kavya4, T. Thameez Nisar5, A. Syed Farook6, S. Thamizhvanan7

Email(s): 1pharmavvv@gmail.com, 2

Address:

    Mohamed Sathak A.J. College Of Pharmacy,Shollinganallur,Chennai-600119.

Published In:   Volume - 5,      Issue - 2,     Year - 2026

DOI: https://doi.org/10.71431/IJRPAS.2026.5203  

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Background: Boerhavia diffusa is traditionally recognized for its pharmacological properties including antioxidant, anti poliferative, anti- inflammatory and antimicrobial activities. Integrating AI and in silico evaluations of plant bioactivities may provide a comprehensive approach to oral cancer. Aim and Objectives: The present study is designed to investigate the therapeutic potential for B. diffusa plant extracts in AI and in silico docking in oral cancer. Materials and Methods: Leaf material of Boerhavia diffusa was collected, shade-dried, and subjected to the ethanolic and aqueous extracts were prepared using Soxhlet apparatus. Phytochemical screening, antioxidant activity DPPH assay. In-silico docking was performed using identified phytoconstituents against apoptotic protein targets retrieved from the RCSB Protein Data Bank including Bcl-2 with ligands from pubchem. An AI model based on CNN was trained and validated for automated oral cancer image classification. Results: The plant extract demonstrated using preliminary tests, antioxidant activity was higher in B.diffusa ethanolic extract compared with aqueous extract and favorable binding affinities in molecular docking. The AI model achieved high accuracy in distinguishing cancerous and non-cancerous images. Conclusion: The integrated approach combining AI-assisted detection with experimental bioactivity and in-silico evaluation of Boerhavia diffusa suggests a multi-disciplinary strategy for improved oral cancer diagnosis and therapeutic exploration.

Cite this article:
Dr. R. Sundhararajan, Mr. V. V. Venkatachalam*, S. Ummu Fathima, A. G. Kavya, T. Thameez Nisar, A. Syed Farook, S. Thamizhvanan. Multi-Model AI-Assisted Early Detection of Oral Cancer Integrated With Phytochemical Profiling, Antioxidant , And In-Silico Target Evaluation of Boerhavia diffusa Linn. IJRPAS, February 2026; 5(2): 20-34.DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2026.5203


     Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation Cell. 2011;144(5):646–674.

2.       Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide. CA Cancer J Clin. 2018;68(6):394–424.

3.       Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48.

4.       Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45(4–5):309–316.

5.       Rivera C. Essentials of oral cancer. Int J Clin Exp Pathol. 2015;8(9):11884–11894.

6.       Petersen PE. Oral cancer prevention and control – The approach of the World Health Organization. Community Dent Oral Epidemiol. 2009;37(1):1–7.

7.       Scully C, Bagan JV. Oral squamous cell carcinoma overview. Oral Oncol. 2009;45(4–5):301–308.

8.       Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, et al. Cancer statistics for the year 2025: Global cancer burden. Int J Cancer. 2021;149(4):778–789.

9.       Lipinski CA. Drug-like properties and the Rule of Five. Adv Drug Deliv Rev. 2001;46(1–3):3–26.

10.     Lipinski CA. Experimental and computational approaches to drug discovery. 1997.

11.     Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, et al. AutoDock Vina: Improving the speed and accuracy of docking. J Comput Chem. 2009;30(16):2785–2791.

12.     Liu Y, Grimm M, Dai WT, Hou MC, Xiao ZX, Cao Y. CB-Dock2: Improved protein–ligand blind docking server. Nucleic Acids Res. 2022;50(W1):W159–W164.

13.     Adams JM, Cory S. The BCL-2 apoptosis regulators as targets in cancer therapy. Oncogene. 2007;26(9):1324–1337.

14.     Cory S, Huang DC, Adams JM. The BCL-2 family: Roles in cell survival and oncogenesis. Nat Rev Cancer. 2002;2(9):647–656.

15.     Blois MS. Antioxidant determinations by the use of a stable free radical. Nature. 1958;181(4617):1199–1200.

16.     Harborne JB. Phytochemical methods: A guide to modern techniques of plant analysis. 3rd ed. London: Chapman & Hall; 1998.

17.     Singh RH, Udupa KN, Kulshrestha VK. Pharmacological properties of Boerhavia diffusa. J Ethnopharmacol. 1992;36(2):111–117.

18.     Apu AS, Liza MS, Jamaluddin ATM, Howlader MA, Saha RK, Rizwan F, et al. Anti-inflammatory activity of Boerhavia diffusa. Pharm Biol. 2012;50(9):1123–1128.

Related Images:



Recent Images



Green Synthesized Zinc Oxide Nanoparticles from Mimusops elengi Flowers: UV Characterization and Antidiabetic Potential
From Mist to Medicine: Wound healing Revolution with Liquid Sprays
Development and Evaluation of Monoherbal Fast Dissolving Oral Film (FDOF) From The Root Extract of Achyranthes aspera Linn for the Treatment of Snake Bites
Plastic Blood: Synthetic Blood Substitutes in Emergency Medicine for Patient Transfusion
Multi-Model AI-Assisted Early Detection of Oral Cancer Integrated With Phytochemical Profiling, Antioxidant , And In-Silico Target Evaluation of Boerhavia diffusa Linn
Assessment of Amplitude of Accommodation (A.A)   Among HIV Subjects Taking Antiretroviral Drugs (ARV)
A Systematic Review of Botany, Traditional Uses, Phytochemistry and Pharmacology of Different Alstonia Species
CRISPR-Cas Systems in Targeted Drug Delivery and Gene Therapy: An Emerging Approach to Precision Medicine
Evaluation of In-vitro Anti-diabetic activity in Ethanolic Stem Extract of Euphobia hirta
Evolving Landscape of Medical Device Vigilance in India: Current Status and Future Directions of MvPI

Tags